Edition:
India

Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

2.45USD
17 Aug 2018
Change (% chg)

$-0.38 (-13.27%)
Prev Close
$2.83
Open
$2.85
Day's High
$2.85
Day's Low
$2.38
Volume
717,188
Avg. Vol
110,214
52-wk High
$5.80
52-wk Low
$2.35

Chart for

About

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's... (more)

Overall

Beta: 0.45
Market Cap(Mil.): $165.38
Shares Outstanding(Mil.): 31.35
Dividend: --
Yield (%): --

Financials

  ADMP.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -0.89 -- --
ROI: -68.80 15.07 14.61
ROE: -79.58 16.59 16.33

BRIEF-Adamis Pharmaceuticals Updates Symjepi Commercialization Plans

* ADAMIS PHARMACEUTICALS UPDATES SYMJEPI COMMERCIALIZATION PLANS

23 Feb 2018

Competitors

  Price Chg
GlaxoSmithKline plc (GSK.L) 1,617.00 +7.00

Earnings vs. Estimates